Coronavirus Update: After FDA Sneaks Out Guidance, Trump’s Vaccine Dream Is Over
Plus Europe Fast Tracks Pfizer/BioNTech Vaccine
After threats to overrule the agency, the Trump administration has indicated that the stricter guidance will be allowed to stand.
You may also be interested in...
Analysts are confident that Pfizer/BioNTech’s mRNA vaccine will prove its safety and efficacy – but waiting a little longer for more robust data could be for the best.
The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.